HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mathisen, D. J. Articles by Peabody, J. Search for Related Content PubMed PubMed Citation Articles by Mathisen, D. J. Articles by Peabody, J.

The Annals of Thoracic Surgery, Vol 27, 295-299, Copyright © 1979 by The Society of Thoracic Surgeons

ARTICLES

The role of thoracotomy in the management of pulmonary metastases from malignant melanoma

DJ Mathisen, MW Flye and J Peabody

Thirty-three patients over a 21-year period underwent thoracotomy for resection of suspected pulmonary metastases from malignant melanoma. Eleven patients were found to have nonmalignant disease (Group 1); 10 were found to have unresectable disease (Group 2); and 12 were rendered disease-free (Group 3). Of the patients found to have melanoma, 20 of 22 received post-operative chemotherapy. The median survival of the patients in Group 2 was 10.5 months (3 to 20 months); in Group 3 it was 12 months (3 to 35 months). There were no 5-year survivors. No factors distinguished the three groups preoperatively. Surgical resection still offers the greatest chance for long-term survival, based on reports of patients in the literature who have survived longer than 5 years following resection of pulmonary metastases from melanoma. Thoracotomy is especially useful for staging purposes in those patients found to have no metastatic disease.

This article has been cited by other articles:

				H. B. Neuman, A. Patel, C. Hanlon, J. D. Wolchok, A. N. Houghton, and D. G. Coit Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival Ann. Surg. Oncol., October 1, 2007; 14(10): 2847 - 2853. [Abstract] [Full Text] [PDF]

				L. Tafra, P. S. Dale, L. A. Wanek, K. P. Ramming, and D. L. Morton Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 119 - 129. [Abstract] [Full Text]